Kenanga IB offers world's first Hang Seng Biotech Index structured warrants


From left: Nancy Cheng, Executive Director and Head of Operations of Hang Seng Indexes Company; Linda Luk, Executive Director and Product Strategist (ETF); Gilbert Lee, Executive Chairman; Nicholas Ho, Commissioner for Belt and Road of the HKSAR Government; Muzambli Markam, Consul General of Malaysia in Hong Kong SAR and Macao SAR; Philip Lim, Head of Equity Markets and Group Head of Equity Derivatives of Kenanga Investment Bank; Kenneth Teoh, Deputy Head of Equity Derivatives and Head of Equity Derivatives Trading; and Isabelle Zhen, Head of Group Equity Marketing

KUALA LUMPUR: Kenanga Investment Bank Bhd has announced the world's first structured warrants linked to the Hang Seng Biotech Index (HSBIO) under its flagship brand, NagaWarrants by Kenanga.

In a statement, it said the warrants, HSBIO-CAA (0661AA) and HSBIO-HBA (0661BA), provide Malaysian investors with exposure to Hong Kong’s biotechnology and healthcare sector, one of Asia’s most compelling long-term growth themes driven by demographic shifts, rising healthcare demand and continued medical innovation. 

The HSBIO tracks 30 of the largest biotechnology and healthcare companies listed in Hong Kong. The index, which gained 64.5% in 2025, outperformed other Hong Kong benchmarks, including the Hang Seng Index (HSI), Hang Seng China Enterprises Index (HSSCEI) and Hang Seng TECH Index (HSTECH). 

"This latest launch underscores our focus on delivering differentiated products that broaden investor choice and provide access to a wider range of market opportunities beyond traditional benchmarks,” said Datuk Chay Wai Leong, group managing director of Kenanga Investment Bank.

Philip Lim Kuok Wei, head of equity markets and group head of equity derivatives of Kenanga Investment Bank, added that HSBIO structured warrants provide investors with a familiar way to gain exposure to biotechnology.

"The addition of HSBIO-CAA and HSBIO-HBA broadens the range of Hong Kong market exposures available through NagaWarrants, complementing existing offerings linked to the HSI, HSCEI and HSTECH," he said.

 

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Kenanga IB , warrants , Hang Seng , Biotech

Next In Business News

Critical Holdings’ contract value rises to RM226.68mil
Pantech Global proposes RM31.73mil sale of Klang land
AHB Holdings, Seri Beskaya to establish strategic JV
CTOS Digital estimates RM12mil in Patami impact from cybersecurity incident
Land 33 to acquire Penang land for RM32.3mil
Lianson Fleet acquires bulk carrier for RM93.9mil
FBM KLCI closed marginally higher
HTP acquires 30% stake in Mentiga Corp for RM21mil
Ekonusa Bhd eyes ACE Market listing
AI boom bolstered growth in global trade,� benefiting China and India, IMF says

Others Also Read